Theranica Bio-Electronics LTD

Theranica develops advanced, clinically proven, safe and affordable electroceuticals, addressing a few of world's most prevalent neurological pain diseases.
The company's first product, Nerivio, is an innovative FDA-authorized, non-invasive, smartphone-operated, prescribed wearable for the acute treatment of migraine in patients 12 years of age or older. In November 2019 Nerivio was named one of TIME's 100 Best Inventions of the year under the healthcare category.